Review Article: Obesity and Infertility

  • Meena S. Farman College of Science, University of Anbar, Anbar, IRAQ
  • Marwa A. Akoul College of Science, University of Anbar, Anbar, IRAQ
Keywords: cole crops, conventional, health issue, IPM, Kavre

Abstract

Obesity is a main health problem, that affects people all over the world. According to recent articles, obese patients should be denied any therapy to aim improving ovulation rates and achieving pregnancy until their BMI is reduced. We believe that this approach does not solve the issue, but rather exacerbates the maternal and perinatal complications linked to fertility clinics. Obesity independent of polycystic ovary syndrome (PCOS) is related with anovulation, and a weight loss alone is an effective treatment for inducing ovulation in both obese women with or not PCOS. As a result, weight-loss lifestyle programs should be considered an ovulation induction therapy, with due consideration for a possible pregnancy in an obese woman.

Obesity has been linked to menstrual irregularities and infertility, Despite the fact that a critical mass of adipose tissue is needed for development female reproductive function. The severity of fat tissue distribution and obesity are important factors that affect the female reproductive system. The mechanisms of pathogenetic that link them aren't well understood. Insulin resistance and hyperinsulinemia are common in obese, especially those women with upper obesity of body, as are hyperandrogenemia, increased peripheral aromatization of androgens to oestrogens, altered secretion of gonadotrophin, and reduced (SHBG), decreased growth hormone (GH) , insulin like growth factor binding proteins (IGFBPs), elevated level of leptin and changed neuroregulation of the hypothalamic‐pituitary‐gonadal axis.

Downloads

Download data is not yet available.

References

[1] McGee EA, Hsueh AJ. Initial and cyclic recruitment of ovarian follicles.Endocr Rev. 2015;21:200–14.
[2] Duggal PS, Van Der Hoek KH, Milner CR, Ryan NK, Armstrong DT, MagoffinDA, et al. The in vivo and in vitro effects of exogenous leptin on ovulationin the rat. Endocrinology. 2014;141(6):1971.
[3] Sim KA, Partridge SR, Sainsbury A. Does weight loss in overweight or obesewomen improve fertility treatment outcomes? A systematic review. ObesComorbidity. 2014;15:839–50.
[4] Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2015; 307: 426-30.
[5] Pasquali R, Pelusi C, Genghini S, Cacciari M, Gambineri A. Obesity and reproductive disorders in women. Hum Reprod Update 2015; 4: 359-72.
[6] Metwally M, Tuckerman EM, Laird SM, Ledger WL, Li TC. Impact of high body mass index on endometrial morphology and function in the peri-implantation period in women with recurrent miscarriage. Reprod Biomed Online 2016; 14: 328-34.
[7] Håkonsen LB, Thulstrup AM, Aggerholm AS, Olsen J, Bonde JP, Andersen CY, et al. Does weight loss improve semen quality and reproductive hormones 2016;8:12.
[8] Rehana Rehman, Zahir Hussain, Syeda Sadia Fatima Effect of weight status on pregnancy outcome in intra cytoplasmic sperm injection. International Journal of Reproductive BioMedicine. 2016.
[9] need ML, Uhler ML, Grotjan HE, Rapisarda JJ, Lederer KJ, Beltsos AN. Bodymass index: impact on IVF success appears age-related. Hum Reprod. 2016;23:1835–9.
[10] Politi SDE, L. Giorlandino,M. Giolandino,C. Shoulder Dystocia: an evidence-based approach. Journal of Prenatal Medicine 2017;4(3):35-42.
[11] Opray NG, R. Deussen,A, Dodd,J. Directed preconception health programs and interventions for improving pregnancy outcomes for women who are overweight or obese. Cochrane Database of Systematic Reviews 2015.
[12] Schuster M M-LO, Mackeen AD, Feng W, Paglia MJ. The effect of the MFM obesity protocol on cesarean delivery rates. American journal of obstetrics and gynecology 2016;215(4):492-6.
[13] Johansson K CS, Näslund I, Roos N, Trolle Lagerros Y, Granath F, Stephansson O, Neovius M. N Outcomes of pregnancy after bariatric surgery. The New England journal of medicine 2015;372(9):814-24.
[14] Robker RL, Akison LK, Bennet BD, Thrupp PN, Chura LR, Russell DL, et al.Obese women exhibit differences in ovarian metabolites, hormones, andgene expression compared with moderate-weight women. J ClinEndocrinol Metab. 2014;94:1533–40.
[15] Orensen TI, Virtue S, Vidal-Puig A. Obesity as a clinical and public health problem: is there a need for a new definition based on lipotoxicity effects? Biochim Biophys Acta. 2015; 1801:400–4.
[16] Nderson RA, Nelson SM, Wallace WH. Measuring anti-Müllerian hormonefor the assessment of ovarian reserve: when and for whom is it indicated?Maturitas.2013;71(1):28–33.
[17] Shwartz DR, Lazar MA. Human resistin: found in translation from mouse toman. Trends Endocrinol Metab. 2015;22:259–65.
[18] Metwally M, Tuckerman EM, Laird SM, Ledger WL, Li TC. Impact of highbody mass index on endometrial morphology and function in the peri-implantation period in women with recurrent miscarriage. Reprod BioMedOnline.2017;14:328–34.
[19] Quaas A, Dokras A. Diagnosis and treatment of unexplained infertility. RevObstet Gynecol. 2015;1(2):69–76.
[20] Cırık DA, Dilbaz B. What do we know about metabolic syndrome in adolescents with PCOS? J Turk Ger Gynecol Assoc 2014; 15: 49-55.
[21] Pratt LA, Brody DJ. Depression and obesity in the U.S. adult house-hold population, 2005-2010. NCHS Data BrieF 2015; 167: 1-8.
[22] Bellver J, Cruz F, MartínezMC, Ferro J, Ramírez JF, Pellicer A, Garrido N. Female overweight is not associated with a higher embryo euploidy rate in first trimester miscarriages karyotyped by hysteroembryoscopy. Fertil Steril 2017; 96: 931-3.
[23] Jungheim ES, Travieso JL, Hopeman MM. Weighing the impact of obesity on female reproductive function and fertility. Nutr Rev 2017; 71: 3-8.
[24] Håkonsen LB, Thulstrup AM, Aggerholm AS, Olsen J, Bonde JP, Andersen CY, et al. Does weight loss improve semen quality and reproductive hormones? Results from a cohort of severely obese men. Reprod Health 2018; 8: 24.
[25] Linne Y. Effects of obesity on women’s reproduction and complica-tions during pregnancy. Obes Rev 2018; 5: 137-43.
[26] Dechaud H, Anahory T, Reyftmann L, Loup V, Hamamah S, Hedon B. Obesity does not adversely affect results in patients who are undergoing in vitro fertilization and embryo transfer. Eur J Obstet Gynecol Reprod Biol 2019; 127: 88-93.
[27] Souter I, Baltagi LM, Kuleta D, Meeker JD, Petrozza JC. Women, weight, and fertility: The effect of body mass index on the outcome of superovulation/intrauterine insemination cycles. Fertil Steril 2019; 95: 1042-7.
[28] Fedorcsak P, Dale PO, Storeng R, Ertzeid G, Bjercke S, Oldereid N, et al. Impact of overweight and underweight on assisted reproduction treatment. Hum Reprod 2013; 19: 2523-2528.
[29] Linne Y. Effects of obesity on women’s reproduction and complications during pregnancy. Obes Rev 2014; 5: 137-143.
[30] Pandey S, Maheswari A, Bhattacharya S. Should access to fertility treatment be determined by female body mass index. Hum Reprod 2015; 25: 815-820.
[31] Wise LA, Rothman KJ, Mikkelsen EM, Sørensen HT, Riis A, Hatch EE. An internet-based prospective study of body size and time-to-pregnancy. Hum Reprod 2010; 25: 253-264.
[32] Bellver J, Ayllon Y, Ferrando M, Melo M, Goyri E, Pellicer A, et al. Female obesity impairs in vitro fertilization outcome without affecting embryo quality. Fertil Steril 2016; 93: 447-454.
[33] Dokras A, Baredziak L, Blaine J, Syrop C, Van Voorhis BJ, Sparks A. Obstetric outcomes after in vitro fertilization in obese and morbidly obese women. Obstet Gynecol 2015; 108: 61-69.40.
[34] Lim SS, Norman RJ, Davies MJ, Moran LJ. The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis. Obesity Reveiw.2018;14:95-109.
[35] Banker M, Sorathiya D, Shah S. Effect of Body Mass Index on the Outcome of In-Vitro Fertilization/Intracytoplasmic Sperm Injection in Women. Journal of Human Reproductive Sciences. 2017;10(1): 37-43.
[36] Bailey AP, Hawkins LK, Missmer SA, Correia KF, Yanushpolsky EH. Effect of body mass index on in vitro fertilization outcomes in women with polycystic ovary syndrome. American Journal of Obstetrics and Gynecology.2014;211:163.e1-6.
[37] Moslehi N, Shab-Bidar S, Ramezani T, Mirmiran P, Azizi F. Is ovarian reserve associated with body mass index and obesity in reproductive aged women? A meta-analysis. Menapause. 2018; 25(9):1046-1055).
[38] Metwally M, Saravelos SH, Ledger WL, Li TC. Body mass index and risk of miscarriage in women with recurrent miscarriage. Fertil Steril 2012; 94: 290-5.
[39] Dechaud H, Anahory T, Reyftmann L, Loup V, Hamamah S, Hedon B. Obesity does not adversely affect results in patients who are undergoing in vitro fertilization and embryo transfer. Eur J Obstet Gynecol Reprod Biol 2012; 127: 88-93.
[40] Barlow SE, Dietz WH. Obesity evaluation and treatment: expert committee recommendations. Pediatrics 2014;102: 1–11.
[41] Must A, Dallal GE, Dietz WH. Reference data for obesity: 85th and 95th percentiles of body mass index (wt/ht2 ) and triceps skinfold thickness. Am J Clin Nutr 2012;53:839–46.
[42] Guillaume M. Defining obesity in childhood: current practice. Am J Clin Nutr 2013;70(suppl):126S–30S.
[43] Guo SS, Chumlea WC. Tracking of body mass index in children in relation to overweight in adulthood. Am J Clin Nutr 2012;70(suppl):145S–8S.
[44] Balen AH, Rutherford AJ. Managing anovulatory infertility and polycystic ovary syndrome. BMJ. 2015;335(7621):663–6.
[45] Cousineau TM, Domar AD. Psychological impact of infertility. Best Pract Res , Cl Ob. 2016;21(2):293–308.
[46] Janet W, et al. Adolescent body mass index and infertility caused by ovulatory disorder. AJOG. 2011;171(1):171–7.
[47] Talmor A, Dunphy B. Female obesity and infertility. Best Pract Res Clin Obstet Gynaecol. 2015;29:498–506.
[48] Pen˜a M, Bacallao J. Obesity and poverty. Washington: Scientific publication no. 576. Pan American Health Organization, 2010, 41–49.
[49] Rose G. Population distributions of risk and disease. Nutr Metab Cardiovasc Dis 2016;1:37–40.
[50] Willett WC, Dietz WH, Colditz GA. Guidelines for healthy weight. N Engl J Med 2013;341:427–34.
[51] Orio F, et al. Effects of physical exercise on the female reproductive system. Minerva Endocrinol. 2013 Sep;38(3):305–19.
[52] Hug C, Wang J, Ahmad NS, Bogan JS, Tsao TS, Lodish HF. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/ adiponectin. PNAS. 2013;101:10308–13.
[53] ASRM-American Society for Reproductive Medicine. Practice Committee of American Society for reproductive medicine. De nitions of infertility and recurrent pregnancy loss. Fertil Steril. 2010;90:S60.
[54] Dorfman SF. Tobacco and fertility: our responsabilities. Fertil Steril. 2012; 89(3):502–4.
[55] Curtis KM, Savitz DA, Arbuckle TE. Effect of cigarette smoking, caffeine consumption, and alcohol intake on fecundability. Am J Epidemiol. 2016; 146:32–41.
[56] Huxley RR, Shiell AW, Law CM. The role of size at birth and postnatal catch-up growth in determining systolic blood pressure: a systematic review of the literature. J Hypertens 2011;18:815–31.
[57] Schroeder DG, Martorell R, Flores R. Infant and child growth and fatness and fat distribution in Guatemalan adults. Am J Epidemiol 1999;149:177–85.
[58] James WPT, Reeds PJ. Nutrient partitioning. In: Bray GA, Bouchard C, James WPT, editors. Handbook on obesity. New York: Marcel Dekker, 2010:555–571.
[59] King RB. Subfecundity and anxiety in a nationally representative sample. Soc Sci Med. 2017;56(4):739–51.
[60] Klonoff-Cohen H, Natarajan L. The concerns during assisted reproductive technologies (CART) scale and pregnancy outcomes. Fertil Steril. 2013;81(4):982–8.
[61] Lawson C, et al. Occupational exposures among nurses and risk of spontaneous abortion. Am J Obstet Gynecol. 2012;206(4):327.e1–327.8.
[62] Pasquali R, Pelusi C, Genghini S, Cacciari M, Gambineri A. Obesity and Reproductive disorders in women. Hum Reprod Update. 2014;9:359–72.
[63] Wise LA, Rothman KJ, Mikkelsen EM, Sorensen HT, Riis A, Hatch EE. An internet-based prospective study of body size and time-to-pregnancy. Hum Reprod. 2012;25:253–64.
[64] Gesink Law DC, Maclehose RF, Longnecker MP. Obesity and time to pregnancy. Hum Reprod. 2015, 22:414–20.
[65] Bellver J, Ayllon Y, Ferrando M, Melo M, Goyri E, Pellicer A, Remohi J, Meseguer M. Female obesity impairs in vitro fertilization outcome without affecting embryo quality. Fertil Steril. 2010;93:447–54.
[66] Budak E, Fernandezsanchez M, Bellver J, Cervero A, Simon C, Pellicer A. Interactions of the hormones leptin, ghrelin, adiponectin, resistin, and PYY3-36 with the reproductive system. Fertil Steril. 2011;85:1563–81.
[67] Brannian JD, Zhao Y, McElroy M. Leptin inhibits gonadotrophin- stimulated granulosa cell proge sterone production by antagonizing insulin action. Hum Reprod. 2018;14:1445–8.
[68] Brannian JD, Zhao Y, McElroy M. Leptin inhibits gonadotrophin- stimulated granulosa cell proge sterone production by antagonizing insulin action. Hum Reprod. 2018;14:1445–8.
[69] Quaas A, Dokras A. Diagnosis and treatment of unexplained infertility. Rev Obstet Gynecol. 2012;1(2):69–76.
[70] Chavarro JE, Rich-Edwards JW, Rosner BA, Willett WC. Diet and lifestyle in the prevention of ovulatory disorder infertility. Obstet Gynecol. 2013;110: 1050–8.
[71] Thompson D, Wolf AM. The medical care cost burden of obesity. Obes Rev 2014;2:189
[72] Templeton A. Infertility and the establishment of pregnancy-overview. Br Med Bull. 2016;56:577–87.
[73] Greil AL, Slauson-Blevins K, McQuillan J. The experience of infertility: a review of recent literature. Sociol Health Illn. 2010;32(1):140–62.
[74] Cousineau TM, Domar AD. Psychological impact of infertility. Best Pract Res Cl Ob. 2016;21(2):293–308.
[75] Wen LM, Rissel C, Baur LA, et al. A 3-Arm randomised controlled trial of Communicating Healthy Beginnings Advice by Telephone (CHAT) to mothers with infants to prevent childhood obesity. BMC Public Health. 2017; 17:79. [PubMed: 28088203
[76] Yang Z, Huffman SL. Nutrition in pregnancy and early childhood and associations with obesity in developing countries. Matern Child Nutr. 2013; 9(Suppl 1):105–119.
[77] Patro B, Liber A, Zalewski B, et al. Maternal and paternal body mass index and offspring obesity: a systematic review. Ann Nutr Metab. 2013; 63:32–41.
[78] Prior LJ, Davern PJ, Burke SL, et al. Exposure to a high-fat diet during development alters leptin and ghrelin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits. Hypertension. 2014; 63:338–345.
[79] Samuelsson AM, Matthews PA, Argenton M, et al. Diet-induced obesity in female mice leads to offspring hyperphagia, adiposity, hypertension, and insulin resistance: a novel murine model of developmental programming. Hypertension. 2014; 51:383–392.
[80] Alfaradhi MZ, Fernandez-Twinn DS, Martin-Gronert MS, et al. Oxidative stress and altered lipid homeostasis in the programming of offspring fatty liver by maternal obesity. Am J Physiol Regul Integr Comp Physiol. 2014; 307:R26–R34.
[81] Jungheim ES, Travieso JL, Carson KR, Moley KH. Obesity and repro ductive functions. Obstet Gynecol Clin North Am 2012; 39: 479-93.
[82] Landres IV, Milki AA, Lathi BR. Karyotype of miscarriages in rela tion to maternal weight Hum Reprod 2010; 25: 1123-26.
[83] Rittenberg V, Seshadri S, Sunkara SK, Sobaleva S, Oteng-Ntim EEl-Toukhy T. Effect of body mass index on IVF treatment outcome: an updated systematic review and meta-analysis. Reprod Biomed Online 2011; 23: 421-39.
[84] Chen X, Jia X, Qiao J, Guan Y, Kang J. Adipokines in reproductive function: a link between obesity and polycystic ovary syndrome. J Mol Endocrin 2015; 50: 21-37.
[85] Cırık DA, Dilbaz B. What do we know about metabolic syndrome in adolescents with PCOS? J Turk Ger Gynecol Assoc 2014; 15: 49-55.
[86] Samuelsson AM, Matthews PA, Argenton M, et al. Diet-induced obesity in female mice leads to offspring hyperphagia, adiposity, hypertension, and insulin resistance: a novel murine model of developmental programming. Hypertension. 2011; 51:383–392.
[87] Dhar M, Zhu M, Impey S, et al. Leptin induces hippocampal synaptogenesis via CREB-regulated microRNA-132 suppression of p250GAP. Mol Endocrinol. 2014; 28:1073–1087.
[88] Penfold NC, Ozanne SE. Developmental programming by maternal obesity in 2015: outcomes,mechanisms, and potential interventions. Horm Behav. 2015; 76:143–152. Provides possible mechanisms by which obesity may mediate developmental programming.
[89] Valckx SD, De Pauw I, De Neubourg D, et al. BMI-related metabolic composition of the follicular fluid of women undergoing assisted reproductive treatment and the consequences for oocyte and embryo quality. Hum Reprod. 2012; 27:3531–3539.
[90] Wozniak SE, Gee LL, Wachtel MS, Frezza EE. Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci. 2013; 54:1847–1856.
[91] Merhi Z, Buyuk E, Berger DS, et al. Leptin suppresses anti-Mullerian hormone gene expression through the JAK2/STAT3 pathway in luteinized granulosa cells of women undergoing IVF. Hum Reprod. 2013; 28:1661–1669.
[92] Catalano PM, Farrell K, Thomas A, et al. Perinatal risk factors for childhood obesity and metabolic dysregulation. Am J Clin Nutr. 2015; 90:1303–1313.
[93] Ministère de la santé et des services sociaux du Québec, Diabète Québec. Meal planning for people with diabetes at a glance. Direction des communications du Ministère de la santé et des services sociaux; Montréal: Diabète Québec. 2014.
[94] Canadian society of exercise physiology. Canadian physical activity and sedentary behaviour guide- lines. 2011. 32 p.
[95] Lv SS, Wang JY, Wang XQ, Wang Y, Xu Y Serum vitamin D status and in vitro fertilization outcomes: a systematic review and meta-analysis. Arch Gynecol Obstet. 2016;293(6):1339-45.
[96] Sobaleva S, El-Toukhy T. The impact of raised BMI on the outcome of assisted reproduction: current concepts. J Obstet Gynaecol. 2011;31(7):561-5.
[97] Jungheim ES, Travieso JL, Carson KR, Moley KH. Obesity and repro ductive functions. Obstet Gynecol Clin North Am 2012; 39: 479-93.
[98] Linne Y. Effects of obesity on women’s reproduction and complica tions during pregnancy. Obes Rev 2012; 5: 137-43.
[99] Gil-Campos M, Canete RR, Gil A. Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr 2013; 23: 963-74.
[100] Al-Azemi M, Omu FE, Omu AE. The effect of obesity on the out come of infertility management in women with polycystic ovary syndrome. Arch Gynecol Obstet 2011; 270: 205-10.
[101] Loh S, Wang JX, Matthews CD. The influence of body mass index, basal FSH and age on the response to gonadotrophin stimulation in non- polycystic ovarian syndrome patients. Hum Reprod 2011; 17: 1207-11.
[102] Haslam DW, James WP. Obesity. Lancet 2016; 366: 1197-209.
[103] Gesink Law DC, Maclehose RF, Longnecker MP. Obesity and time to pregnancy. Hum Reprod 2015; 22: 414-20.
[104] Lashen H, Fear K, Sturdee DW. Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case- control study. Hum Reprod 2014; 19: 1644-6.
[105] Ramlau-Hansen CH, Thulstrup AM, Nohr EA, Bonde JP, Sørensen TI, Olsen J. Subfecundity in overweight and obese couples. Hum Reprod 2012; 22: 1634-7.
[106] Callaway LK, Prins JB, Chang AM, McIntyre HD. The prevalence and impact of overweight and obesity in an Australian Obstetric population. Med J Aust 2016; 184: 56-9.
[107] Lee B, Shao J. Adiponectin and energy homeostasis. Rev Endocr Metab Disord 2014; 15: 149-56.
Published
2021-04-06
How to Cite
Meena S. Farman, & Marwa A. Akoul. (2021). Review Article: Obesity and Infertility. International Journal for Research in Applied Sciences and Biotechnology, 8(2), 173-183. https://doi.org/10.31033/ijrasb.8.2.23
Section
Articles